Home NDC 0187-5190 Benzaclin
Product NDC 0187-5190
11-digit product format 001875190
Labeler code 0187
Product ID 0187-5190_4d429947-c5e7-4bb1-8881-6fd591b637b2
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Clindamycin phosphate and benzoyl peroxide
Dosage form GEL
Route TOPICAL
Labeler Bausch Health US LLC
Application NDA050756
Marketing category NDA
Marketing start 2000-12-21
Marketing end 0000-00-00
Substance BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Active strength 50 mg/g; mg/g
Pharmacologic classes Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 37 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N050756-001 BENZACLIN BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 N050756-002 BENZACLIN BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 84e616aacf4f…2026-08-18 06:07:40 2026-07 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL AB RLD, RS 2000-12-21 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL AB RLD, RS 2000-12-21 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL AB RLD, RS 2000-12-21 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL AB RLD, RS 2000-12-21 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 74a2ff9319b5…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0187-5190 BENZACLIN (CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE) GEL [BAUSCH HEALTH US LLC] 15 Legacy NDC 20230204_4c6b2aca-d940-42af-a068-418f015d277a.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0187-5190-25 00187519025 1 JAR in 1 CARTON (0187-5190-25) > 25 g in 1 JAR 1 jar 2000-12-21 0000-00-00 No No Current 0187-5190-35 00187519035 1 BOTTLE, PUMP in 1 CARTON (0187-5190-35) > 35 g in 1 BOTTLE, PUMP 2000-12-21 0000-00-00 No No Current 0187-5190-50 00187519050 1 BOTTLE, PUMP in 1 CARTON (0187-5190-50) > 50 g in 1 BOTTLE, PUMP 2000-12-21 0000-00-00 No No Current